Cord blood rescues stroke-induced changes in splenocyte phenotype and function

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Stroke induces significant immuno-inflammatory responses.
• The neuroprotective mechanisms of human umbilical cord blood cells (HUCBC) in stroke models are not fully understood.
• HUCBC are known to migrate to injured tissues, including potentially the spleen following stroke.

Purpose of the Study:

• To investigate the immunomodulatory effects of HUCBC in a rat middle cerebral artery occlusion (MCAO) stroke model.
• To determine if HUCBC-mediated protection is linked to the modulation of splenic immune responses.
• To explore the impact of HUCBC on T-cell populations and cytokine production post-stroke.

Main Methods:

• Induction of MCAO in rats to create a stroke model.
• Administration of HUCBC treatment following MCAO.
• Assessment of spleen weight, splenic CD8+ T-cell counts, and brain injury extent.
• Splenocyte proliferation assays to analyze cytokine production (IL-10 and IFN-gamma).

Main Results:

• MCAO caused spleen size reduction and decreased CD8+ T-cell counts, correlating with ischemic damage.
• HUCBC treatment reversed spleen size reduction and restored CD8+ T-cell counts.
• HUCBC treatment significantly reduced brain injury in MCAO rats.
• HUCBC treatment modulated T-cell responses by increasing IL-10 and decreasing IFN-gamma production.

Conclusions:

• HUCBC exhibit neuroprotective effects in the rat MCAO stroke model.
• HUCBC mediate protection through an immunomodulatory mechanism involving spleen and T-cell responses.
• This study suggests a novel role for HUCBC in regulating post-stroke inflammation.